Regeneron Provides Update on Biologics License Application for Linvoseltamab
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Regeneron (NASDAQ: REGN) | Delayed: 817.54 +4.27 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $813.27 | 52 Week High | $592.36 | |||
| Open | $826.14 | 52 Week Low | $325.35 | |||
| Day High | $828.19 | P/E | 214.58 | |||
| Day Low | $811.63 | EPS | $3.81 | |||
| Volume | 638,738 | |||||
